82 results
Page 2 of 5
8-K
EX-99.1
vrlhgk8d 9c
8 Aug 23
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:03am
8-K
EX-3.1
s3k73g2nywo
21 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:32pm
8-K
EX-99.2
b8u52 jqm5
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
EX-99.1
i9y58tp34u52 je0
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
04p e29td9
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
EX-99.1
j89 2y6b76msxx
22 Nov 22
Regulation FD Disclosure
7:31am
8-K
EX-99.2
e6qqefm4f
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
i02w1d8r7ch u46actg
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.1
5rpmy 83ep1y
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.2
poqmq01w
10 Dec 21
Regulation FD Disclosure
8:16am
424B5
vapzpox 03
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-10.3
aelte0z4j3 gzhh
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-10.2
5bd1f
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
424B5
2iis08z jfvum8anm82
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
z65vy
14 Dec 20
Prospectus supplement for primary offering
4:48pm